Sinopia Biosciences has joined the NVIDIA Inception program, which is designed to nurture startups revolutionizing industries with advancements in AI and data sciences. Sinopia Biosciences is a computational biology company that deploys machine learning, systems biology, and bioinformatics for drug discovery. Sinopia deploys its proprietary algorithms to understand pharmacology at an unprecedented level of biochemical detail to aid in improving the standard of care in multiple disease areas.
The NVIDIA Inception program enables Sinopia to better expand its extensive expertise in omics data and network biology into deep learning and artificial intelligence to continue improving its internal algorithms for drug discovery.
NVIDIA’s Inception program is a virtual accelerator program that helps startups during critical stages of product development, prototyping and deployment. Every Inception member gets a custom set of ongoing benefits, from hardware grants and marketing support to training with deep learning experts.